Evidence map›Paper›PMID 31770068›Full record

Trial reportHuman vaccines & immunotherapeutics2020

Lot-to-lot consistency study of an

Ying-Ying Su, Bi-Zhen Lin, Hui Zhao, Juan Li, Zhi-Jie Lin, You-Lin Qiao, Li-Hui Wei, Yue-Mei Hu, Rong-Cheng Li, Si-Jie Zhuang and 7 more

Open access · bronzeAbstract readClinical Trial, Phase IIIMulticenter StudyRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Human vaccines & immunotherapeutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Immunogenicity of anHuman vaccines & immunotherapeutics · 2020
    Trial
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 1 country.

Ying-Ying SuThe State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University , Xiamen, Fujian, China.
Bi-Zhen LinVaccine R&D Department, Xiamen Innovax Biotech Company , Xiamen, Fujian, China.
Hui ZhaoNational Institute for Food and Drug Control, Division of Respiratory Virus Vaccines , Beijing, China.
Juan LiNational Institute for Food and Drug Control, Division of Respiratory Virus Vaccines , Beijing, China.
Zhi-Jie LinVaccine R&D Department, Xiamen Innovax Biotech Company , Xiamen, Fujian, China.
You-Lin QiaoNational Cancer Center, National Center for Cancer Clinical Research, the Cancer Institute, Chinese Academy of Medical Sciences/Peking Union Medical College , Beijing, China.
Li-Hui WeiDepartment of Obstetrics and Gynecology, Peking University People's Hospital , Beijing, China.
Yue-Mei HuDepartment of Vaccine Evaluation, Jiangsu Provincial Center for Disease Control and Prevention , Nanjing, Jiangsu, China.
Rong-Cheng LiCenter for Vaccine Clinical Research, Guangxi Center for Disease Control and Prevention , Nanning, Guangxi, China.
Si-Jie ZhuangThe State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University , Xiamen, Fujian, China.
Guang SunVaccine R&D Department, Xiamen Innovax Biotech Company , Xiamen, Fujian, China.
Zi-Zheng ZhengThe State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University , Xiamen, Fujian, China.
Shou-Jie HuangThe State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University , Xiamen, Fujian, China.
Ting WuThe State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University , Xiamen, Fujian, China.
Jun ZhangThe State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University , Xiamen, Fujian, China.
Hui-Rong PanVaccine R&D Department, Xiamen Innovax Biotech Company , Xiamen, Fujian, China.
Chang-Gui LiNational Institute for Food and Drug Control, Division of Respiratory Virus Vaccines , Beijing, China.
Xiamen University · CNNational Institutes for Food and Drug Control · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNGuangxi Center for Disease Prevention and Control · CNJiangsu Provincial Center for Disease Control and Prevention · CNPeking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An

Indexed as

Papillomavirus InfectionsPapillomavirus VaccinesAdultAntibodies, ViralDouble-Blind MethodEscherichia coliFemaleHuman papillomavirus 16Human papillomavirus 18HumansImmunogenicity, VaccineAntibodies, ViralPapillomavirus VaccinesbivalentEscherichia coliHuman papillomavirus vaccineimmunogenicitylot-to-lot consistencysafety

Identifiers

PMID31770068
PMCPMC7482731
OpenAlexW2991140947

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.